Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
NCT06747871

Opioids, Low Nicotine Cigarettes, and Chronic Pain

Led by Duke University · Updated on 2026-01-09

60

Participants Needed

1

Research Sites

119 weeks

Total Duration

On this page

Sponsors

D

Duke University

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the effects of switching to very low nicotine content (VLNC) cigarettes versus normal nicotine content (NNC) cigarettes on craving, withdrawal, and pain among individuals with chronic pain who smoke cigarettes daily and are attending office-based buprenorphine treatment (OBBT).

CONDITIONS

Official Title

Opioids, Low Nicotine Cigarettes, and Chronic Pain

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 21 years or older who smoke cigarettes daily
  • Chronic non-cancer musculoskeletal pain due to structural changes (e.g., low back pain, osteoarthritis)
  • Stable office-based buprenorphine treatment for opioid use disorder for at least 30 days
  • Self-reported smoking of at least 10 cigarettes per day
  • Expired breath carbon monoxide level greater than 8 ppm
  • Smartphone capable of running ecological momentary assessment software
  • Willingness to consider quitting smoking
Not Eligible

You will not qualify if you...

  • Pain caused by cancer
  • Other significant health problems
  • Major surgery within the past 6 months or planned surgery during the study period
  • Current disability litigation
  • Use of electronic cigarettes or other non-cigarette tobacco products more than 9 of the past 30 days
  • Current use of nicotine replacement therapy or other smoking cessation treatments
  • Current daily or near-daily cannabis use
  • History of psychotic disorder
  • Acute suicidality or unstable psychiatric disorder
  • Positive pregnancy test
  • Actively seeking smoking cessation treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

North Pavilion

Durham, North Carolina, United States, 27705

Actively Recruiting

Loading map...

Research Team

C

Clinical Research Coordinator

CONTACT

C

Clinical Research Coordinator

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here